Current features: 2021

A two part look at the emergence of psoriasis as a disease in its own right and the progression through to the current scientific breakthroughs.  

The British Society for Immunology has launched a brand new website to provide the latest information, news and resources on work being done by UK research teams to improve our understanding of vaccines for COVID-19.

COVID-19 remains a serious health risk. You should stay cautious to help protect yourself and others. The latest advice from the UK Government says...

We are pleased that the latest edition of Skin ‘n’ Bones Connection has now been published. You will notice in this issue that there are reports about how real peoples’ lived experiences are starting to influence research agendas.

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease.

A person's psoriasis or psoriatic arthritis can affect the lives of partners and family members, but this important impact is often ignored.

PAPAA working through our Connect Immune Research partnership, is excited to be part of an innovative new grant call...

The British Psoriatic Arthritis Consortium (BritPACT) worked with the James Lind Alliance (JLA) to run a priority setting partnership (PSP). They have created a national top 10 list of research priorities for psoriatic arthritis, agreed upon by people with psoriatic arthritis, carers and clinicians. This marks the culmination of the psoriasis arthritis PSP.

Bowel Research UK has joined the Connect Immune Research initiative, which includes the type 1 diabetes charity JDRF, the MS Society, Versus Arthritis, the British Society for Immunology, Alopecia UK, the Psoriasis and Psoriatic Arthritis Alliance (PAPAA) and Coeliac UK.

Skin 'n' Bones Connection issue 53 is now available. The journal is aimed at people affected by psoriasis and psoriatic arthritis.